Self-assembling T7 phage syringes with modular genomes for targeted delivery of penicillin against beta-lactam-resistant Escherichia coli
Hyunjin Shim

TL;DR
This study develops self-assembling phage-based structures to deliver antibiotics directly into resistant bacteria, demonstrating effective reduction of resistant E. coli populations and offering a new approach to combat antibiotic resistance.
Contribution
It introduces a novel method of creating modular, self-assembling phage structures as targeted antibiotic delivery vehicles using cell-free systems.
Findings
Phage syringes effectively kill penicillin-resistant E. coli.
Modular phage structures can be synthesized in vitro with cargo.
Delivered antibiotics outperform free penicillin in resistant bacteria.
Abstract
Bacteriophages are promising alternative antimicrobial agents due to their high specificity for host bacteria and minimal immunogenicity in humans. However, their therapeutic application is limited by their nature as biological entities, which can lead to unintended evolutionary consequences such as horizontal gene transfer. In this study, we address these challenges by repurposing only the structural components of bacteriophages as vesicles to deliver antibiotics directly into the cytoplasm of bacterial hosts. This approach is based on two key hypotheses: first, antibiotics such as beta-lactams remain effective against resistant bacteria if injected directly into the cytoplasm, bypassing resistance mechanisms; second, phage structures can be synthesized and self-assembled in vitro using modular genomes and cell-free protein expression systems to carry small molecules such as…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBacteriophages and microbial interactions · Monoclonal and Polyclonal Antibodies Research · Innovative Microfluidic and Catalytic Techniques Innovation
